Janel King
Director, Business Development
Janel King
Director, Business Development
Janel is a director of Business Development for SRS Acquiom. She works on the West Coast to develop new business by working closely with strategic buyers, law firms, deal parties and investors. In her efforts, she focuses on getting in front of as many people as possible by securing meetings, attending conferences and events, and sharing the value of SRS Acquiom.
Before joining SRS Acquiom, Janel spent her career in both Sales and Customer Success where she excelled at expanding market share and increasing adoption. Most recently, she leveraged her sales and technical background to help companies utilize artificial intelligence to accelerate sales, increase forecasting accuracy, and manage their pipelines. She’s worked with the largest enterprise companies in the world, and thrives in a fast-paced environment.
Janel enjoys spending time with her three children, traveling, baking, and listening to music. She supports organizations such as the Pat Finucane Centre and Justice for the Forgotten, and regularly travels to Ireland. She has a B.S. in Information Systems from the University of Phoenix.
How can we help?
SRS Acquiom provides a comprehensive suite of solutions for private target M&A and bilateral or syndicated loan transactions that can be utilized individually or in combination, customized for the needs of each transaction.
I am interested in
Learn moreFeatured Insights, Resources & Studies
Deal Terms Analysis
2024 M&A Deal Terms Study
Deal Terms Analysis
2024 M&A Claims Insights Report
Deal Terms Analysis
2024 M&A Working Capital PPA Study
Deal Terms Analysis
Life Sciences
2023 SRS Acquiom Life Sciences M&A Study
Shareholder Representation
Common Myths About Hiring a Professional Shareholder Representative
Loan Agency
Credit-Spread Adjustments and the State of SOFR Today
Deal Terms Analysis
2024 M&A Deal Terms Study
Deal Terms Analysis
2024 M&A Claims Insights Report
Deal Terms Analysis
2024 M&A Working Capital PPA Study
Deal Terms Analysis
Life Sciences
2023 SRS Acquiom Life Sciences M&A Study
Shareholder Representation
Common Myths About Hiring a Professional Shareholder Representative
Loan Agency
Credit-Spread Adjustments and the State of SOFR Today